Report Detail
Global Valbazen Anthelmintic Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4743048 |
- 28 September, 2026 |
- Global |
- 105 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Valbazen Anthelmintic market size was valued at US$ 219 million in 2025 and is forecast to a readjusted size of US$ 364 million by 2032 with a CAGR of 7.6% during review period.
Valbazen is a brand name for an anthelmintic (deworming) medication used to treat various internal parasites in animals, particularly livestock such as cattle, sheep, goats, and poultry. The active ingredient in Valbazen is albendazole, which is a broad-spectrum anthelmintic that works by disrupting the metabolism of the parasites, ultimately leading to their death.
The market for Valbazen Anthelmintic is influenced by several drivers. Valbazen is a widely used anthelmintic medication in the livestock and veterinary industry to treat internal parasitic infections in various animals. The demand for anthelmintic treatments like Valbazen is driven by several factors that contribute to the growth of the market:
Livestock Health and Productivity: The primary driver for the Valbazen Anthelmintic market is the need to maintain the health and productivity of livestock. Parasitic infections can lead to reduced growth rates, poor feed conversion, decreased milk production, and other negative impacts on animal health.
Parasite Control: The effectiveness of Valbazen in treating a broad spectrum of internal parasites, including gastrointestinal worms and liver flukes, makes it a valuable tool for controlling parasitic infestations that can harm animals and impact their performance.
Animal Welfare: Treating parasitic infections contributes to the overall well-being and welfare of animals by alleviating discomfort and preventing serious health issues caused by internal parasites.
Preventive Care: Anthelmintic treatments like Valbazen are often used preventively as part of herd health management programs to reduce the risk of parasitic infections and maintain the overall health of livestock populations.
Veterinary Recommendations: Veterinarians play a key role in recommending and prescribing anthelmintic treatments based on their expertise and assessments of the health status of animals.
Global Livestock Industry: The global demand for animal-derived products such as meat, milk, and eggs drives the need to maintain healthy livestock populations through effective parasite control.
Increasing Livestock Production: As the world population grows, the demand for livestock products is also increasing, creating a higher demand for effective animal health management.
Resistance Management: Developing resistance to existing anthelmintic treatments is a concern in the livestock industry. Valbazen can be used strategically to help manage resistance issues by providing an alternative treatment option.
Regulatory Compliance: Regulatory agencies often require regular deworming and parasite control in livestock production systems, contributing to the demand for effective anthelmintic products like Valbazen.
Farm Efficiency: Healthy animals are more efficient in converting feed into products like meat and milk. Anthelmintic treatments help maintain optimal farm efficiency and productivity.
Emerging Markets: As livestock production expands in developing regions, the demand for anthelmintic treatments to ensure animal health and productivity is likely to grow.
Research and Development: Continued research into animal health and parasitic infections leads to the development of improved anthelmintic formulations and treatment protocols.
Sustainable Livestock Practices: Maintaining animal health through anthelmintic treatments aligns with sustainable and ethical livestock production practices.
Animal Genetics: With advancements in animal genetics and breeding, the need for effective health management, including parasite control, becomes more critical to optimize genetic potential.
This report is a detailed and comprehensive analysis for global Valbazen Anthelmintic market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Valbazen Anthelmintic market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Valbazen Anthelmintic market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Valbazen Anthelmintic market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Valbazen Anthelmintic market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Valbazen Anthelmintic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Valbazen Anthelmintic market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include K.A. Malle Pharmaceutica, Lasa Supergenerics Limited, Fredun Pharmaceuticals, Supharma Chem, Salius Pharma, HUBEI KEYI PHARMACEUTICAL INDUSTRY, Huazhong Pharmaceutical, Jiangsu Quality Horizons Pharmtech, Hubei Zhongjiachem Pharmaceutical, Suzhou Homesun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Valbazen Anthelmintic market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablet
Capsule
Market segment by Application
Human Use
Veterinary Use
Major players covered
K.A. Malle Pharmaceutica
Lasa Supergenerics Limited
Fredun Pharmaceuticals
Supharma Chem
Salius Pharma
HUBEI KEYI PHARMACEUTICAL INDUSTRY
Huazhong Pharmaceutical
Jiangsu Quality Horizons Pharmtech
Hubei Zhongjiachem Pharmaceutical
Suzhou Homesun Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Valbazen Anthelmintic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Valbazen Anthelmintic, with price, sales quantity, revenue, and global market share of Valbazen Anthelmintic from 2021 to 2026.
Chapter 3, the Valbazen Anthelmintic competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Valbazen Anthelmintic breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Valbazen Anthelmintic market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Valbazen Anthelmintic.
Chapter 14 and 15, to describe Valbazen Anthelmintic sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Valbazen Anthelmintic Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Tablet
- 1.3.3 Capsule
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Valbazen Anthelmintic Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Human Use
- 1.4.3 Veterinary Use
- 1.5 Global Valbazen Anthelmintic Market Size & Forecast
- 1.5.1 Global Valbazen Anthelmintic Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Valbazen Anthelmintic Sales Quantity (2021-2032)
- 1.5.3 Global Valbazen Anthelmintic Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 K.A. Malle Pharmaceutica
- 2.1.1 K.A. Malle Pharmaceutica Details
- 2.1.2 K.A. Malle Pharmaceutica Major Business
- 2.1.3 K.A. Malle Pharmaceutica Valbazen Anthelmintic Product and Services
- 2.1.4 K.A. Malle Pharmaceutica Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 K.A. Malle Pharmaceutica Recent Developments/Updates
- 2.2 Lasa Supergenerics Limited
- 2.2.1 Lasa Supergenerics Limited Details
- 2.2.2 Lasa Supergenerics Limited Major Business
- 2.2.3 Lasa Supergenerics Limited Valbazen Anthelmintic Product and Services
- 2.2.4 Lasa Supergenerics Limited Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Lasa Supergenerics Limited Recent Developments/Updates
- 2.3 Fredun Pharmaceuticals
- 2.3.1 Fredun Pharmaceuticals Details
- 2.3.2 Fredun Pharmaceuticals Major Business
- 2.3.3 Fredun Pharmaceuticals Valbazen Anthelmintic Product and Services
- 2.3.4 Fredun Pharmaceuticals Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Fredun Pharmaceuticals Recent Developments/Updates
- 2.4 Supharma Chem
- 2.4.1 Supharma Chem Details
- 2.4.2 Supharma Chem Major Business
- 2.4.3 Supharma Chem Valbazen Anthelmintic Product and Services
- 2.4.4 Supharma Chem Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Supharma Chem Recent Developments/Updates
- 2.5 Salius Pharma
- 2.5.1 Salius Pharma Details
- 2.5.2 Salius Pharma Major Business
- 2.5.3 Salius Pharma Valbazen Anthelmintic Product and Services
- 2.5.4 Salius Pharma Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Salius Pharma Recent Developments/Updates
- 2.6 HUBEI KEYI PHARMACEUTICAL INDUSTRY
- 2.6.1 HUBEI KEYI PHARMACEUTICAL INDUSTRY Details
- 2.6.2 HUBEI KEYI PHARMACEUTICAL INDUSTRY Major Business
- 2.6.3 HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Product and Services
- 2.6.4 HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 HUBEI KEYI PHARMACEUTICAL INDUSTRY Recent Developments/Updates
- 2.7 Huazhong Pharmaceutical
- 2.7.1 Huazhong Pharmaceutical Details
- 2.7.2 Huazhong Pharmaceutical Major Business
- 2.7.3 Huazhong Pharmaceutical Valbazen Anthelmintic Product and Services
- 2.7.4 Huazhong Pharmaceutical Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Huazhong Pharmaceutical Recent Developments/Updates
- 2.8 Jiangsu Quality Horizons Pharmtech
- 2.8.1 Jiangsu Quality Horizons Pharmtech Details
- 2.8.2 Jiangsu Quality Horizons Pharmtech Major Business
- 2.8.3 Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Product and Services
- 2.8.4 Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Jiangsu Quality Horizons Pharmtech Recent Developments/Updates
- 2.9 Hubei Zhongjiachem Pharmaceutical
- 2.9.1 Hubei Zhongjiachem Pharmaceutical Details
- 2.9.2 Hubei Zhongjiachem Pharmaceutical Major Business
- 2.9.3 Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Product and Services
- 2.9.4 Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Hubei Zhongjiachem Pharmaceutical Recent Developments/Updates
- 2.10 Suzhou Homesun Pharmaceutical
- 2.10.1 Suzhou Homesun Pharmaceutical Details
- 2.10.2 Suzhou Homesun Pharmaceutical Major Business
- 2.10.3 Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Product and Services
- 2.10.4 Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Valbazen Anthelmintic by Manufacturer
- 3.1 Global Valbazen Anthelmintic Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Valbazen Anthelmintic Revenue by Manufacturer (2021-2026)
- 3.3 Global Valbazen Anthelmintic Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Valbazen Anthelmintic by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Valbazen Anthelmintic Manufacturer Market Share in 2025
- 3.4.3 Top 6 Valbazen Anthelmintic Manufacturer Market Share in 2025
- 3.5 Valbazen Anthelmintic Market: Overall Company Footprint Analysis
- 3.5.1 Valbazen Anthelmintic Market: Region Footprint
- 3.5.2 Valbazen Anthelmintic Market: Company Product Type Footprint
- 3.5.3 Valbazen Anthelmintic Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Valbazen Anthelmintic Market Size by Region
- 4.1.1 Global Valbazen Anthelmintic Sales Quantity by Region (2021-2032)
- 4.1.2 Global Valbazen Anthelmintic Consumption Value by Region (2021-2032)
- 4.1.3 Global Valbazen Anthelmintic Average Price by Region (2021-2032)
- 4.2 North America Valbazen Anthelmintic Consumption Value (2021-2032)
- 4.3 Europe Valbazen Anthelmintic Consumption Value (2021-2032)
- 4.4 Asia-Pacific Valbazen Anthelmintic Consumption Value (2021-2032)
- 4.5 South America Valbazen Anthelmintic Consumption Value (2021-2032)
- 4.6 Middle East & Africa Valbazen Anthelmintic Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Valbazen Anthelmintic Sales Quantity by Type (2021-2032)
- 5.2 Global Valbazen Anthelmintic Consumption Value by Type (2021-2032)
- 5.3 Global Valbazen Anthelmintic Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Valbazen Anthelmintic Sales Quantity by Application (2021-2032)
- 6.2 Global Valbazen Anthelmintic Consumption Value by Application (2021-2032)
- 6.3 Global Valbazen Anthelmintic Average Price by Application (2021-2032)
7 North America
- 7.1 North America Valbazen Anthelmintic Sales Quantity by Type (2021-2032)
- 7.2 North America Valbazen Anthelmintic Sales Quantity by Application (2021-2032)
- 7.3 North America Valbazen Anthelmintic Market Size by Country
- 7.3.1 North America Valbazen Anthelmintic Sales Quantity by Country (2021-2032)
- 7.3.2 North America Valbazen Anthelmintic Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Valbazen Anthelmintic Sales Quantity by Type (2021-2032)
- 8.2 Europe Valbazen Anthelmintic Sales Quantity by Application (2021-2032)
- 8.3 Europe Valbazen Anthelmintic Market Size by Country
- 8.3.1 Europe Valbazen Anthelmintic Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Valbazen Anthelmintic Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Valbazen Anthelmintic Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Valbazen Anthelmintic Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Valbazen Anthelmintic Market Size by Region
- 9.3.1 Asia-Pacific Valbazen Anthelmintic Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Valbazen Anthelmintic Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Valbazen Anthelmintic Sales Quantity by Type (2021-2032)
- 10.2 South America Valbazen Anthelmintic Sales Quantity by Application (2021-2032)
- 10.3 South America Valbazen Anthelmintic Market Size by Country
- 10.3.1 South America Valbazen Anthelmintic Sales Quantity by Country (2021-2032)
- 10.3.2 South America Valbazen Anthelmintic Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Valbazen Anthelmintic Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Valbazen Anthelmintic Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Valbazen Anthelmintic Market Size by Country
- 11.3.1 Middle East & Africa Valbazen Anthelmintic Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Valbazen Anthelmintic Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Valbazen Anthelmintic Market Drivers
- 12.2 Valbazen Anthelmintic Market Restraints
- 12.3 Valbazen Anthelmintic Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Valbazen Anthelmintic and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Valbazen Anthelmintic
- 13.3 Valbazen Anthelmintic Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Valbazen Anthelmintic Typical Distributors
- 14.3 Valbazen Anthelmintic Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Valbazen Anthelmintic. Industry analysis & Market Report on Valbazen Anthelmintic is a syndicated market report, published as Global Valbazen Anthelmintic Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Valbazen Anthelmintic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
